CTT Pharmaceutical Holdings Signs LOI for Strategic Partnership

May 14, 2026 — Leads & Copy — CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed a letter of intent with a European company for a potential strategic partnership, according to a press release issued Thursday.

The partnership could provide CTT with additional opportunities to monetize its patented technology in both Europe and the United States.

CTT Pharma plans to update shareholders as more details become available.

CTT Pharmaceutical Holdings, Inc. specializes in developing and commercializing thin film oral drug delivery systems. These systems are designed for rapid onset, enhanced patient convenience, and efficient absorption.

The company's patented micelle-based thin film platform aims to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT focuses on scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.

813-606-0060

Source: CTT Pharmaceutical Holdings, Inc.